Arca
Skip to content
Tools
Tools

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine…

Recall D-0607-2018, part of FDA recall event 79457. See Pine Pharmaceuticals's company page.

Pine Pharmaceuticals, LLC started this Class III drug recall on Mar 5, 2018 (voluntary: firm initiated); FDA lists it as terminated, terminated Apr 23, 2018.

  • Classification: Class III
  • Started: Mar 5, 2018
  • Status: Terminated

Why It Was Recalled

Class III

Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.

Record

Product
Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01
Quantity
136 units
Lots and codes
Lot#: 18098@1, Exp. 7/16/2018
Distribution
NY only
Recalling firm
Pine Pharmaceuticals, LLC, Tonawanda, NY, United States
How the firm notified
Letter
FDA classified
Mar 26, 2018

Pine Pharmaceuticals, LLC's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.